Paraneoplastic disorders of the peripheral nervous system

Handbook of Clinical Neurology

Volumn 105, Issue , 2012, Pages 865-870

  Giometto, Bruno ^a   Vitaliani, Roberta ^a,b   Briani, Chiara ^b  

^a Radiological Department   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855560638     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53502-3.00028-8     Document Type: Chapter

References (32)

1. Camdessanché J.P., Antoine J.C., Honnorat J., et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain 2002, 125:166-175.
2. Clouston P.D., Saper C.B., Arbizu T., et al. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 1992, 42:1944-1950.
3. Dalakas M.C. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 2004, 17:561-567.
4. Dalmau J., Graus F., Rosenblum M.K., et al. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992, 71:59-72.
5. Denny-Brown D. Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 1948, 11:73-87.
6. Dispenzieri A. POEMS syndrome. Blood Rev 2007, 21:285-299.
7. Drlicek M., Bodenteich A., Setinek U., et al. T cell-mediated paraneoplastic ganglionitis: an autopsy case. Acta Neuropathol (Berl) 2000, 99:599-602.
8. Eggers C., Hagel C., Pfeiffer G. Anti-Hu-associated paraneoplastic sensory neuropathy with peripheral nerve demyelination and microvasculitis. J Neurol Sci 1998, 155:178-181.
9. Fonseca R., Hayman S. Waldenström macroglobulinaemia. Br J Haematol 2007, 138:700-720.
10. Gallais V., Crikx B., Belaich S. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. Ann Dermatol Venereol 1996, 123:722-726.
11. Gawler J. Neurological manifestations of myeloma and their management. Myeloma: Biology and Management 2004, 269-293. Saunders, Elsevier, Philadelphia. 3rd ed. J.S. Malpas, D.E. Bergsagel, R.A. Kyl (Eds.).
12. Giometto B., Tavolato B., Graus F. Autoimmunity in paraneoplastic neurological syndromes. Brain Pathol 1999, 9:261-274.
13. Graus F., Dalmau J., Rene R., et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997, 51:2866-2872.
14. Graus F., Keime-Guilbert F., Renè R., et al. Anti-Hu associated paraneoplastic encephalomielytis: analysis of 200 patients. Brain 2001, 124:1138-1148.
15. Graus F., Delattre J.Y., Antoine J.C., et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004, 78:1135-1140.
16. Hart I.K., Maddison P., Newson-Davis J., et al. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002, 125:1887-1895.
17. Isaacs H. A syndrome of continuous muscle fibre activity. J Neurol Neurosurg Psychiatry 1961, 24:319-325.
18. Johnson P.C., Rolak L.A., Hamilton R.H., et al. Paraneoplastic vasculitis of nerve: a remote effect of cancer. Ann Neurol 1979, 5:437-444.
19. Levin M.I., Mozzafar T., Al Lozi M.T. Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology 1998, 50:764-767.
20. Levine T., Pestronk A., Florence J., et al. Peripheral neuropathies in Waldenström's macroglobulinaemia. J Neurol Neurosurg Psychiatry 2006, 77:224-228.
21. Lorusso L., Hart I.K., Ferrari D., et al. Autonomic paraneoplastic neurological syndromes (2007). Autoimmun Rev 2007, 6:162-168.
22. Lozeron P., Adams D. Monoclonal gammopathy and neuropathy. Curr Opin Neurol 2007, 20:536-541.
23. O'Neill J.H., Murray N.M., Nesom-Davis J. Lambert and Eaton myasthenic syndrome: a review of 50 cases. Brain 1988, 111:577-596.
24. Oh S.J. Paraneoplastic vasculitis of the peripheral nervous system. Neurol Clin 1997, 15:849-863.
25. Oh S.J., Gurtekin Y., Dropcho E.J., et al. Anti-Hu antibody neuropathy: a clinical, electrophysiological, and pathological study. Clin Neurophysiol 2005, 116:28-34.
26. Posner J.B. Paraneoplastic syndromes. Neurologic Complications of Cancer. Contemporary Neurology series 1995, 353-383. F.A. Davis, Philadelphia. J.B. Posner (Ed.).
27. Scarlato M., Previtali S.C., Carpo M., et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 2005, 128:1911-1920.
28. Siurgeirsson B., Lindelöf B., Edhag O., et al. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992, 326:363-367.
29. Vigliani M.C., Magistrello M., Polo P., et al. Risk of cancer in patients with Guillain-Barré syndrome (GBS). A population-based study. J Neurol 2004, 251:321-326.
30. Wirtz P.W., Smallegange T.M., Wintzen A.R., et al. Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: and analysis of 227 published cases. Clin Neurol Neurosurg 2002, 104:359-363.
31. Wirtz P.W., Wintzen A.R., Verschuuren J.J. Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancer. Muscle Nerve 2005, 32:226-229.
32. Younger D.S., Dalmau J., Inghirami G., et al. Anti-Hu-associated peripheral nerve and muscle microvasculitis. Neurology 1994, 75:181-183.